Research & Literature

Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.

Yamasaki Y, Satoh M, Mizushima M, et al.

Modern rheumatology 2016; (26(3)):403-9 doi:10.3109/14397595.2015.1091155.

Antisynthetase syndrome: An under-recognized cause of interstitial lung disease.

Maturu VN, Lakshman A, Bal A, et al.

Lung India : official organ of Indian Chest Society 2016; (33(1)):20-6 doi:10.4103/0970-2113.173055.

Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study.

Andersson H, Aaløkken TM, Günther A, et al.

The Journal of rheumatology 2016; (43(6)):1107-13 doi:10.3899/jrheum.151067.

Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.

Trallero-Araguás E, Grau-Junyent JM, Labirua-Iturburu A, et al.

Seminars in arthritis and rheumatism 2016; (46(2)):225-231 doi:10.1016/j.semarthrit.2016.03.011.

Acute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase Syndrome.

Kim SH, Park IN

Tuberculosis and respiratory diseases 2016; (79(3)):188-92 doi:10.4046/trd.2016.79.3.188.

Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti-EJ antibody) syndrome.

Ishiguro T, Kagiyama N, Kawate E, et al.

Clinical case reports 2017; (5(1)):61-65 doi:10.1002/ccr3.747.

"Hiker's feet": a novel cutaneous finding in the inflammatory myopathies.

Cox JT, Gullotti DM, Mecoli CA, et al.

Clinical rheumatology 2017; (36(7)):1683-1686 doi:10.1007/s10067-017-3598-5.

Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.

Shi J, Li S, Yang H, et al.

The Journal of rheumatology 2017; (44(7)):1051-1057 doi:10.3899/jrheum.161480.

Skeletal Muscle Involvement in Antisynthetase Syndrome.

Noguchi E, Uruha A, Suzuki S, et al.

JAMA neurology 2017; (74(8)):992-999 doi:10.1001/jamaneurol.2017.0934.

Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.

Sharma N, Putman MS, Vij R, et al.

The Journal of rheumatology 2017; (44(11)):1612-1618 doi:10.3899/jrheum.161217.

A 64-year-old woman with interstitial lung disease and positive antibodies against aminoacyl-transfer RNA synthetases in the absence of myositis: presentation of an anti-PL-12 positive antisynthetase syndrome.

Ghysen K, Leys M

Acta clinica Belgica 2018; (73(5)):389-392 doi:10.1080/17843286.2017.1403133.

[Clinical and radiological features of adult patients with different antisynthetase syndrome based on serum anti-aminoacyl-tRNA synthetase antibody type].

Li S, Huang H, Song XY, et al.

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2017; (40(12)):919-924 doi:10.3760/cma.j.issn.1001-0939.2017.12.011.

Idiopathic Inflammatory Myopathy and Antisynthetase Syndrome: Early Diagnosis by 99mTc-HDP Bone Scintigraphy.

Fernández-Rodríguez P, Martín-Marcuartu JJ, Jiménez-Hoyuela JM

Clinical nuclear medicine 2018; (43(12)):939-940 doi:10.1097/RLU.0000000000002312.

Nailfold videocapillaroscopy in antisynthetase syndrome.

Cassone G, Sebastiani M, Cavagna L, et al.

Reumatismo 2018; (70(4)):257-258 doi:10.4081/reumatismo.2018.1105.

Polymyositis with antisynthetase syndrome presented with lobular panniculitis: A case report.

Rungcharunthanakul A, Sampattavanich N

Clinical case reports 2019; (7(1)):128-130 doi:10.1002/ccr3.1839.

Acute hypoxic respiratory failure secondary to antisynthetase syndrome: A case report and review of literature.

Cancel M, Song M

Respiratory medicine case reports 2019; (26()):288-291 doi:10.1016/j.rmcr.2019.02.009.

Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria.

Greco M, García de Yébenes MJ, Alarcón I, et al.

Annals of the rheumatic diseases 2019; (78(9)):1291-1292 doi:10.1136/annrheumdis-2019-215031.

Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.

Liu H, Xie S, Liang T, et al.

European radiology 2019; (29(10)):5349-5357 doi:10.1007/s00330-019-06152-5.

Lesson of the month 2: Fever, arthralgias and hyperkeratotic, scaling and fissuring eruptions of the hands.

Zampeli E, Moutsopoulos HM

Clinical medicine (London, England) 2019; (19(3)):255-256 doi:10.7861/clinmedicine.19-3-255.

[Antisynthetase syndromes].

Bauhammer J, Fiehn C

Zeitschrift fur Rheumatologie 2019; (78(7)):645-655 doi:10.1007/s00393-019-0665-0.

Antisynthetase syndrome presenting as interstitial lung disease: a case report.

Badshah A, Haider I, Pervez S, Humayun M

Journal of medical case reports 2019; (13(1)):241 doi:10.1186/s13256-019-2146-0.

Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.

Fukamatsu H, Hirai Y, Miyake T, et al.

The Journal of dermatology 2019; (46(10)):886-897 doi:10.1111/1346-8138.15049.

Pulmonary involvement in antisynthetase syndrome.

Gasparotto M, Gatto M, Saccon F, et al.

Current opinion in rheumatology 2019; (31(6)):603-610 doi:10.1097/BOR.0000000000000663.

Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.

Rüegg CA, Maurer B, Laube I, Scholtze D

BMJ case reports 2019; (12(9)) doi:10.1136/bcr-2019-231006.

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.

Cavagna L, Trallero-Araguás E, Meloni F, et al.

Journal of clinical medicine 2019; (8(11)) doi:10.3390/jcm8112013.

Anti-Jo-1 Syndrome Often Misdiagnosed as Rheumatoid Arthritis (for Many Years): A Single-Center Experience.

Kumar RR, Jha S, Dhooria A, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(4)):150-155 doi:10.1097/RHU.0000000000001234.

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.

Tansley SL, Li D, Betteridge ZE, McHugh NJ

Rheumatology (Oxford, England) 2020; (59(8)):2109-2114 doi:10.1093/rheumatology/keaa021.

PL-7 Antisynthetase Syndrome in Association with Sjögren's, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.

Jawaid M, Ross Y, Kamran M

Case reports in rheumatology 2020; (2020()):4736476 doi:10.1155/2020/4736476.

Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.

Zhang Y, Ge Y, Yang H, et al.

Clinical rheumatology 2020; (39(8)):2417-2424 doi:10.1007/s10067-020-04979-8.

Patient-Reported Outcomes (PROs) in Acute Symptomatic Seizure (ASyS) Versus Patients With Established Epilepsy.

Newey CR, Thompson NR, George P, et al.

The Neurohospitalist 2020; (10(3)):193-200 doi:10.1177/1941874419900709.

The antisynthetase syndrome.

Robinson D, Scholz B

Proceedings (Baylor University. Medical Center) 2020; (33(3)):401-403 doi:10.1080/08998280.2020.1764818.

Antisynthetase syndrome and pulmonary hypertension: report of two cases and review of the literature.

García-Fernández A, Quezada-Loaiza CA, de la Puente-Bujidos C

Modern rheumatology case reports 2021; (5(1)):152-155 doi:10.1080/24725625.2020.1794521.

The clinical manifestations at the onset of antisynthetase syndrome: A chameleon with multiple faces.

Baccaro ACCD, Behrens Pinto GL, Carboni RCS, Shinjo SK

Reumatismo 2020; (72(2)):86-92 doi:10.4081/reumatismo.2020.1275.

Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies.

Yanagihara T, Suzuki K, Egashira A, et al.

Respiratory medicine case reports 2020; (31()):101272 doi:10.1016/j.rmcr.2020.101272.

Antisynthetase syndrome - much more than just a myopathy.

Opinc AH, Makowska JS

Seminars in arthritis and rheumatism 2021; (51(1)):72-83 doi:10.1016/j.semarthrit.2020.09.020.

Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.

Barratt SL, Adamali HH, Cotton C, et al.

BMJ open respiratory research 2021; (8(1)) doi:10.1136/bmjresp-2020-000829.

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.

Vacchi C, Manfredi A, Cassone G, et al.

Drugs in context 2021; (10()) doi:10.7573/dic.2020-8-7.

Antisynthetase Syndrome-Associated Interstitial Lung Disease: Monitoring of Immunosuppressive Treatment Effects by Chest Computed Tomography.

Korsten P, Rademacher JG, Riedel L, et al.

Frontiers in medicine 2020; (7()):609595 doi:10.3389/fmed.2020.609595.

Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies.

Ponce-Gallegos MA, González-Pérez MI, Mejía M, et al.

Life (Basel, Switzerland) 2021; (11(2)) doi:10.3390/life11020174.

Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.

Jiang M, Dong X, Zheng Y

Medicine 2021; (100(19)):e25816 doi:10.1097/MD.0000000000025816.

Mechanic's hand; is it a prodromic sign of disease relapse of anti-synthetase syndrome; a case report.

Rosa CT, Thilakarathne AS, Senevirathne LA, et al.

BMC rheumatology 2021; (5(1)):25 doi:10.1186/s41927-021-00195-2.

High-resolution computed tomography (HRCT) analysis in anti-synthase antibody syndrome with organizing pneumonia.

Li X, Wu Q, Peng S, et al.

Medicina clinica 2022; (159(2)):59-64 doi:10.1016/j.medcli.2021.08.003.

Clinical profile and treatment outcomes in antisynthetase syndrome: a tertiary centre experience.

Sreevilasan SK, Devarasetti P, Narahari NK, et al.

Rheumatology advances in practice 2021; (5(Suppl 2)):ii10-ii18 doi:10.1093/rap/rkab054.

Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.

Laporte A, Mariampillai K, Allenbach Y, et al.

European radiology 2022; (32(5)):3480-3489 doi:10.1007/s00330-021-08411-w.

Skin pigmentation in antisynthetase syndrome.

Wang G, Zhuo N, Tian F, et al.

Journal of cosmetic dermatology 2022; (21(9)):4097-4098 doi:10.1111/jocd.14769.

Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies.

Hiramatsu T, Murano M, Nakai S, et al.

Respiratory medicine case reports 2022; (36()):101606 doi:10.1016/j.rmcr.2022.101606.

Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy.

Hama S, Higashida-Konishi M, Akiyama M, et al.

Internal medicine (Tokyo, Japan) 2022; (61(7)):1085-1091 doi:10.2169/internalmedicine.8579-21.

Echocardiographic characteristics of patients with antisynthetase syndrome.

Bryan JL, Matar R, Raviprasad A, et al.

Pulmonary circulation 2022; (12(2)):e12084 doi:10.1002/pul2.12084.

A Rare Case of Anti-glycyl transfer RNA (tRNA) Synthetase Antibody-Related Non-specific Interstitial Pneumonia.

Khatri Chhetri RC, Gole S, Mallari AJP, et al.

Cureus 2022; (14(6)):e26159 doi:10.7759/cureus.26159.

The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population.

Loganathan A, McMorrow F, Lu H, et al.

Frontiers in immunology 2022; (13()):975939 doi:10.3389/fimmu.2022.975939.

A multidisciplinary approach to the diagnosis of antisynthetase syndrome.

Wells M, Alawi S, Thin KYM, et al.

Frontiers in medicine 2022; (9()):959653 doi:10.3389/fmed.2022.959653.

Antisynthetase syndrome and interstitial lung disease: A case report.

Dahal K, Chaudhary A, Rawal L, et al.

Annals of medicine and surgery (2012) 2022; (82()):104571 doi:10.1016/j.amsu.2022.104571.

Successful treatment of rapid progressive interstitial lung disease in a case of anti-Zo antibody positive anti-synthetase syndrome.

Li Y, Liu G, Yu F, Jiang Y

International journal of rheumatic diseases 2023; (26(2)):370-375 doi:10.1111/1756-185X.14471.

F18-FDG PET/CT in a patient with Antisynthetase Syndrome.

Nazerani-Zemann T, Stanzel S, Gstettner C, et al.

Nuklearmedizin. Nuclear medicine 2023; (62(2)):73-74 doi:10.1055/a-1996-0157.

Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy.

Oka H, Sumitomo S, Shimizu H, et al.

Internal medicine (Tokyo, Japan) 2023; (62(18)):2747-2751 doi:10.2169/internalmedicine.1275-22.

A Case of Antisynthetase Syndrome Initially Presented With Interstitial Lung Disease Mimicking COVID-19.

Elsayed M, Abdelgabar A, Karmani J, Majid M

Journal of medical cases 2023; (14(1)):25-30 doi:10.14740/jmc4031.

Antisynthetase syndrome-related interstitial lung disease (ASyS-ILD): longitudinal imaging findings.

Wu W, Collins BF, Gardner GC, et al.

European radiology 2023; (33(7)):4746-4757 doi:10.1007/s00330-023-09439-w.

Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review.

La Rocca G, Ferro F, Baldini C, et al.

Frontiers in medicine 2023; (10()):1158768 doi:10.3389/fmed.2023.1158768.

Rapidly progressive respiratory failure due to antisynthetase syndrome related interstitial lung disease.

Almubarek M, Boy DP, Lalla U, et al.

Respirology case reports 2023; (11(5)):e01141 doi:10.1002/rcr2.1141.

Antisynthetase Syndrome With Predominant Pulmonary Involvement: A Case Report.

Lima Corrêa de Araújo B, Victor DR, Farias Fontes HM, et al.

Cureus 2023; (15(8)):e43966 doi:10.7759/cureus.43966.

Clinical heterogeneity and prognostic factors of anti-synthetase syndrome: a multi-centred retrospective cohort study.

Tang HS, Tang IYK, Ho RTC, et al.

Rheumatology (Oxford, England) 2025; (64(1)):212-220 doi:10.1093/rheumatology/kead671.

Long-lasting improvement of refractory antisynthetase syndrome with tocilizumab: a report of two cases.

Baumann Benvenuti F, Dudler J

RMD open 2023; (9(4)) doi:10.1136/rmdopen-2023-003599.

Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification.

Wu S, Xiao X, Zhang Y, et al.

Annals of the rheumatic diseases 2024; (83(6)):775-786 doi:10.1136/ard-2023-225284.

Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases.

Mostkowska A, Rousseau G, Raynal NJ

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024; (38(5)):e23536 doi:10.1096/fj.202302259RR.

A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.

Patel P, Marinock JM, Ajmeri A, Brent LH

International journal of molecular sciences 2024; (25(8)) doi:10.3390/ijms25084453.

Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies.

Tzilas V, Tzouvelekis A, Sotiropoulou V, et al.

Frontiers in medicine 2024; (11()):1392659 doi:10.3389/fmed.2024.1392659.

Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.

Yang H, Chen Q, Sun C, et al.

Respiratory research 2024; (25(1)):222 doi:10.1186/s12931-024-02851-w.

Interstitial lung disease in rheumatic diseases: an update of the 2018 review.

Atzeni F, Alciati A, Gozza F, et al.

Expert review of clinical immunology 2025; (21(2)):209-226 doi:10.1080/1744666X.2024.2407536.

Management of anti-melanoma differentiation-associated gene 5 antibody-induced refractory dermatomyositis complicated by interstitial pneumonia using tofacitinib and its outcomes: a case report.

Imai Y, Yorozuya T, Hatakeyama T, et al.

Journal of medical case reports 2024; (18(1)):471 doi:10.1186/s13256-024-04793-9.

Poor prognostic factors for relapse of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies after combination therapy.

Matsuda S, Kotani T, Oe K, et al.

Frontiers in immunology 2024; (15()):1407633 doi:10.3389/fimmu.2024.1407633.

One-year survival benefit of plasma exchange in idiopathic inflammatory myositis patients with progressive interstitial lung disease-a systemic review and meta-analysis.

Tangborwornweerakul B, Phutthinart N, Disayabutr S, Katchamart W

Seminars in arthritis and rheumatism 2024; (69()):152564 doi:10.1016/j.semarthrit.2024.152564.

Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?

Bautista-Sanchez R, Khanna D

Rheumatology and immunology research 2024; (5(3)):157-165 doi:10.2478/rir-2024-0022.

273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023.

Stenzel W, Mammen AL, Gallay L, et al.

Neuromuscular disorders : NMD 2024; (45()):104453 doi:10.1016/j.nmd.2024.104453.

Quantification of autoantibodies using a luminescent profiling method in autoimmune interstitial lung disease.

Burbelo PD, Huapaya JA, Khavandgar Z, et al.

Frontiers in immunology 2024; (15()):1462242 doi:10.3389/fimmu.2024.1462242.

Newer Autoantibodies and Laboratory Assessments in Myositis.

Harvey GR, MacFadyen C, Tansley SL

Current rheumatology reports 2024; (27(1)):5 doi:10.1007/s11926-024-01171-8.

Epidemiology of Antisynthetase Syndrome and Risk of Malignancy in a Population-Based Cohort (1998-2019).

Coffey CM, Hulshizer CA, Crowson CS, et al.

The Journal of rheumatology 2025; (52(3)):280-284 doi:10.3899/jrheum.2024-0945.

Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study.

Sun S, Jin J, Chen J, et al.

Seminars in arthritis and rheumatism 2025; (72()):152712 doi:10.1016/j.semarthrit.2025.152712.

MMF Is an Effective and Safer Treatment Options for Treatment-Naïve Patients With Autoimmune Hepatitis Compared to Azathioprine: A Systematic Review and Meta-Analysis.

Anwar MT, Shahzil M, Arif TB, et al.

Journal of digestive diseases 2025; (26(3-4)):113-128 doi:10.1111/1751-2980.13348.

Clinical-imaging characteristics and management of anti-JO-1 and non-JO-1 anti-synthetase syndrome-associated interstitial lung disease.

Zhou W, Chen R, Chen X, et al.

Rheumatology (Oxford, England) 2025; (64(10)):5295-5303 doi:10.1093/rheumatology/keaf287.

Acute exacerbation of anti-Ha antibody-positive antisynthetase syndrome-associated interstitial lung disease: a case report.

Li Y, Ke J, Huang S, et al.

Frontiers in immunology 2025; (16()):1614777 doi:10.3389/fimmu.2025.1614777.

Anti-synthetase syndrome: A focus on interstitial lung disease as a diagnostic criteria.

Peterson JA, Cook C, Gao H, et al.

Respiratory medicine and research 2025; (88()):101190 doi:10.1016/j.resmer.2025.101190.

Antisynthetase Syndrome With Classic Features and Anti‑PL‑7 Positivity: A Rare Immunologic Variant.

Arrazola-Mendoza KS, González-Chávez HE, De la Peña-Camacho F, et al.

Cureus 2025; (17(9)):e93503 doi:10.7759/cureus.93503.

Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis.

Gono T, Gil-Vila A, Selva-O'Callaghan A, et al.

Seminars in arthritis and rheumatism 2025; (75()):152858 doi:10.1016/j.semarthrit.2025.152858.

Longitudinal change of idiopathic inflammatory myopathy-associated interstitial lung disease on high-resolution computed tomography, a prospective cohort study.

Qiang Y, Wang H, Ni Y, et al.

BMC pulmonary medicine 2025; (25(1)):503 doi:10.1186/s12890-025-03962-w.

Distinct Nailfold Videocapillaroscopy Findings in Patients With Anti-Aminoacyl-tRNA Synthetase Antibodies.

Mugii N, Hamaguchi Y, Fushida N, et al.

The Journal of dermatology 2026; (53(2)):318-322 doi:10.1111/1346-8138.70081.

Distinct phenotypes and prognosis between Jo-1 and non-Jo-1 subtypes in anti-synthetase syndrome: a retrospective cohort study from China.

Zhang X, Wang L, Cheng Q, et al.

Clinical rheumatology 2026; (45(2)):1199-1207 doi:10.1007/s10067-025-07849-3.

Persistent fever: Anti-KS syndrome overlaps with multidrug-resistant infections (MDRO) in a cervical spinal cord injury (CSCI) patient.

Ni X, Lu L, Bi J, et al.

Respiratory medicine case reports 2026; (59()):102369 doi:10.1016/j.rmcr.2026.102369.

Veno-venous ECMO for rapidly progressing interstitial lung disease: A multidisciplinary approach.

Tariq S, O'Hannigan F, Nasir N, et al.

Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) 2026; (12(1)):110-116 doi:10.2478/jccm-2026-0006.

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases.

Düsing C, Györfi AH, Stütz AN, et al.

Nature medicine 2026; (32(4)):1530-1542 doi:10.1038/s41591-026-04238-4.

A Rare Case Report of Antisynthetase Syndrome With Progressive Myopathy and Interstitial Lung Disease in a 38-Year-Old Male.

Ali M, Tariq MU, Hassan M, et al.

Clinical case reports 2026; (14(2)):e72059 doi:10.1002/ccr3.72059.

Checkerboard Hyperkeratosis With Apoptotic Keratinocytes as Features of Mechanic's Hands and Review of the Literature.

Long V, Joel LHL

The American Journal of dermatopathology 2026; (48(4)):278-282 doi:10.1097/DAD.0000000000003231.